TY - JOUR
T1 - Burkholderia pseudomallei as an enteric pathogen
T2 - Identification of virulence factors mediating gastrointestinal infection
AU - Sanchez-Villamil, Javier
AU - Tapia, Daniel
AU - Borlee, Grace I.
AU - Borlee, Bradley R.
AU - Walker, David H.
AU - Torres, Alfredo G.
N1 - Funding Information:
The manuscript was partially supported by NIH NIAID grant AI12660101 and UTMB seed funds awarded to A.G.T. D.T. was funded by an NIH NIAID Research Supplement for Underrepresented Minorities. J.I.S.-V. was supported by the Conacyt ConTex postdoctoral fellowship.
Funding Information:
The manuscript was partially supported by NIH NIAID grant AI12660101 and UTMB seed funds awarded to A.G.T. D.T. was funded by an NIH NIAID Research Supplement for Underrepresented Minorities. J.I.S.-V. was supported by the Conacyt ConTex postdoctoral fellowship. The contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIAID or NIH. J.I.S.-V. and D.T. designed the experiments; J.I.S.-V. and D.T. performed the experiments; G.I.B. identified and verified B. pseudomallei 1026b transposon mutants; and J.I.S.-V., D.T., G.I.B., B.R.B., D.H.W., and A.G.T. wrote the manuscript. J.I.S.-V., D.T., G.I.B., B.R.B., D.H.W., and A.G.T. edited and approved the manuscript.
Publisher Copyright:
© 2020 American Society for Microbiology. All Rights Reserved.
PY - 2021/1
Y1 - 2021/1
N2 - Burkholderia pseudomallei is a Gram-negative bacterium and the causative agent of melioidosis. Despite advances in our understanding of the disease, B. pseudomallei poses a significant health risk, especially in regions of endemicity, where treatment requires prolonged antibiotic therapy. Even though the respiratory and percutaneous routes are well documented and considered the main ways to acquire the pathogen, the gastrointestinal tract is believed to be an underreported and underrecognized route of infection. In the present study, we describe the development of in vitro and in vivo models to study B. pseudomallei gastrointestinal infection. Further, we report that the type 6 secretion system (T6SS) and type 1 fimbriae are important virulence factors required for gastrointestinal infection. Using a human intestinal epithelial cell line and mouse primary intestinal epithelial cells (IECs), we demonstrated that B. pseudomallei adheres, invades, and forms multinucleated giant cells, ultimately leading to cell toxicity. We demonstrated that mannose-sensitive type 1 fimbria is involved in the initial adherence of B. pseudomallei to IECs, although the impact on full virulence was limited. Finally, we also showed that B. pseudomallei requires a functional T6SS for full virulence, bacterial dissemination, and lethality in mice infected by the intragastric route. Overall, we showed that B. pseudomallei is an enteric pathogen and that type 1 fimbria is important for B. pseudomallei intestinal adherence, and we identify a new role for T6SS as a key virulence factor in gastrointestinal infection. These studies highlight the importance of gastrointestinal melioidosis as an understudied route of infection and open a new avenue for the pathogenesis of B. pseudomallei.
AB - Burkholderia pseudomallei is a Gram-negative bacterium and the causative agent of melioidosis. Despite advances in our understanding of the disease, B. pseudomallei poses a significant health risk, especially in regions of endemicity, where treatment requires prolonged antibiotic therapy. Even though the respiratory and percutaneous routes are well documented and considered the main ways to acquire the pathogen, the gastrointestinal tract is believed to be an underreported and underrecognized route of infection. In the present study, we describe the development of in vitro and in vivo models to study B. pseudomallei gastrointestinal infection. Further, we report that the type 6 secretion system (T6SS) and type 1 fimbriae are important virulence factors required for gastrointestinal infection. Using a human intestinal epithelial cell line and mouse primary intestinal epithelial cells (IECs), we demonstrated that B. pseudomallei adheres, invades, and forms multinucleated giant cells, ultimately leading to cell toxicity. We demonstrated that mannose-sensitive type 1 fimbria is involved in the initial adherence of B. pseudomallei to IECs, although the impact on full virulence was limited. Finally, we also showed that B. pseudomallei requires a functional T6SS for full virulence, bacterial dissemination, and lethality in mice infected by the intragastric route. Overall, we showed that B. pseudomallei is an enteric pathogen and that type 1 fimbria is important for B. pseudomallei intestinal adherence, and we identify a new role for T6SS as a key virulence factor in gastrointestinal infection. These studies highlight the importance of gastrointestinal melioidosis as an understudied route of infection and open a new avenue for the pathogenesis of B. pseudomallei.
KW - Burkholderia pseudomallei
KW - GI infection
KW - Melioidosis
KW - Virulence factors
UR - http://www.scopus.com/inward/record.url?scp=85098602880&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85098602880&partnerID=8YFLogxK
U2 - 10.1128/IAI.00654-20
DO - 10.1128/IAI.00654-20
M3 - Article
C2 - 33106293
AN - SCOPUS:85098602880
SN - 0019-9567
VL - 89
JO - Infection and Immunity
JF - Infection and Immunity
IS - 1
M1 - e00654-20
ER -